Log in
The iScreen™ Oral Fluid Drug Screen Cube uses lateral flow chromatographic immunoassay technology to detect drugs and their metabolites in human oral fluid. The collection swab is placed inside the mouth until the saliva saturation indicator confirms that an adequate specimen has been collected. The swab is then inserted into the testing device, where the oral fluid migrates across individual test membranes containing antibodies specific to each targeted drug.
If the drug concentration is below the established screening cutoff level, both the Control (C) and Test (T) lines appear, indicating a negative result. If the drug concentration is equal to or greater than the cutoff level, only the Control (C) line appears, indicating a preliminary positive result.
Because this device provides only preliminary screening results, any positive finding should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS), Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS), or another appropriate confirmatory laboratory method before making medical, legal, employment, or insurance decisions
Amphetamine is a prescription central nervous system (CNS) stimulant commonly used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. It works by increasing certain neurotransmitters in the brain, helping improve focus, attention, and alertness. However, amphetamine is also frequently misused because of its stimulating and performance-enhancing effects.
Due to its abuse potential, amphetamine is routinely included in workplace, clinical, forensic, and rehabilitation drug testing programs.
Increased energy
Improved alertness
Elevated mood
Increased heart rate
Reduced appetite
Restlessness
Anxiety
Insomnia
Long-term misuse may result in dependence, cardiovascular complications, aggression, and mental health disorders.
Speed, Uppers, Bennies, Dexies, Pep Pills, Addys.
Amphetamine is generally detectable in oral fluid for approximately 24–48 hours after use.
Barbiturates are medications that depress the central nervous system (CNS) and are prescribed to treat seizure disorders, anxiety, insomnia, and for anesthesia during certain medical procedures. Although they are prescribed less frequently today, barbiturates still carry a significant risk of misuse, dependence, and overdose.
Because of their sedative effects, barbiturates remain an important component of workplace, clinical, and forensic drug screening programs.
Relaxation
Sedation
Drowsiness
Slowed breathing
Poor coordination
Slurred speech
Dizziness
Confusion
Long-term misuse may lead to dependence, respiratory depression, and overdose
Barbs, Downers, Reds, Blues, Yellow Jackets, Rainbows.
Barbiturates are generally detectable in oral fluid for approximately 1–2 days, depending on the specific medication
Cocaine is a powerful central nervous system stimulant derived from the coca plant. It produces intense but short-lived feelings of euphoria, increased confidence, and energy by rapidly increasing dopamine levels in the brain. Cocaine has a high potential for abuse and addiction and is routinely included in workplace, clinical, and forensic drug testing panels.
Increased energy
Euphoria
Heightened alertness
Rapid heartbeat
Elevated blood pressure
Reduced appetite
Anxiety
Restlessness
Long-term misuse may contribute to heart attack, stroke, depression, and substance dependence.
Coke, Blow, Snow, Crack, Rock, Flake, Yayo, White, Dust.
Cocaine is generally detectable in oral fluid for approximately 24–48 hours after use
MDMA (3,4-Methylenedioxymethamphetamine), commonly known as Ecstasy or Molly, is a synthetic psychoactive drug with stimulant and mild hallucinogenic properties. It increases serotonin, dopamine, and norepinephrine levels in the brain, producing feelings of euphoria, emotional warmth, and increased energy.
Although commonly associated with parties and music festivals, repeated use may lead to dehydration, hyperthermia, cardiovascular complications, and long-term cognitive impairment.
Euphoria
Increased energy
Emotional warmth
Enhanced sensory perception
Increased heart rate
Jaw clenching
Sweating
Dehydration
Long-term misuse may contribute to anxiety, depression, sleep disturbances, and memory problems.
Ecstasy, Molly, X, E, Beans, Adam, Love Drug, Rolls.
MDMA is generally detectable in oral fluid for approximately 24–48 hours after use.
Methamphetamine is a highly addictive synthetic stimulant that affects the brain and central nervous system. It produces intense feelings of euphoria, increased energy, and heightened
alertness. Because of its powerful stimulant effects, methamphetamine has a high risk of abuse and long-term addiction.
Intense euphoria
Increased energy
Heightened alertness
Rapid heartbeat
Elevated blood pressure
Reduced appetite
Anxiety
Aggressive behavior
Long-term misuse may result in severe weight loss, hallucinations, paranoia, memory impairment, and permanent brain damage.
Meth, Crystal Meth, Ice, Glass, Tina, Crank.
Methamphetamine is generally detectable in oral fluid for approximately 24–72 hours after use.
Methadone is a long-acting synthetic opioid prescribed to treat chronic pain and opioid use disorder. It is commonly used in medication-assisted treatment (MAT) programs to help reduce opioid withdrawal symptoms and cravings. While effective when used under medical supervision, methadone also has the potential for misuse, dependence, and overdose.
Because of its abuse potential, methadone is routinely included in workplace, clinical, rehabilitation, and forensic drug testing panels.
Pain relief
Relaxation
Reduced opioid cravings
Drowsiness
Slowed breathing
Sweating
Dizziness
Nausea
Long-term misuse may result in dependence, respiratory depression, irregular heartbeat, overdose, and death.
Fizzies, Dollies, Juice, Amidone, Methadose.
Methadone is generally detectable in oral fluid for approximately 24–48 hours after use
Opiates are naturally occurring opioid drugs derived from the opium poppy, including morphine and codeine. They are commonly prescribed to relieve moderate to severe pain but are also frequently abused because of their pain-relieving and euphoric effects.
Repeated misuse can quickly lead to tolerance, physical dependence, addiction, and life-threatening respiratory depression. Because of their widespread misuse, opiates are routinely included in workplace, clinical, rehabilitation, and forensic drug testing panels.
Pain relief
Euphoria
Relaxation
Drowsiness
Constricted pupils
Slowed breathing
Nausea
Constipation
Long-term misuse may result in opioid dependence, overdose, respiratory failure, coma, and death.
Smack, Dope, H, Horse, Junk, Mud, Big O.
Opiates are generally detectable in oral fluid for approximately 24–48 hours after use
Oxycodone is a semi-synthetic opioid analgesic prescribed to treat moderate to severe pain. It is commonly used after surgery, injury, or for chronic pain management. While highly effective when taken as prescribed, oxycodone also has a high potential for misuse because of its pain-relieving and euphoric effects.
Because oxycodone is one of the most commonly misused prescription opioids, many professional drug screening programs include a dedicated test for this drug.
Pain relief
Euphoria
Relaxation
Drowsiness
Slowed breathing
Dizziness
Nausea
Constipation
Long-term misuse may lead to opioid dependence, overdose, respiratory depression, and death.
Oxy, OCs, Percs, Roxies, Hillbilly Heroin.
Oxycodone is generally detectable in oral fluid for approximately 24–48 hours after use
Phencyclidine (PCP), commonly known as Angel Dust, is a dissociative hallucinogenic drug originally developed as a surgical anesthetic. Although its medical use has been discontinued, PCP continues to be abused because of its powerful hallucinogenic and mind-altering effects.
PCP affects the central nervous system and can significantly alter perception, mood, behavior, and coordination. Because of its unpredictable effects and high abuse potential, it remains an important component of workplace, clinical, and forensic drug screening programs.
Hallucinations
Detachment from reality
Confusion
Aggressive behavior
Numbness
Loss of coordination
Elevated blood pressure
Agitation
Heavy use may result in seizures, psychosis, coma, or death.
Angel Dust, Sherm, Wet, Rocket Fuel, Love Boat, Embalming Fluid.
PCP is generally detectable in oral fluid for approximately 24–72 hours after use
The iScreen™ Oral Fluid Drug Screen Cube (9 Panel) provides a fast, reliable, and non-invasive solution for the preliminary detection of nine commonly abused drugs using oral fluid. Designed for employment and insurance testing, it features an integrated saliva collection swab with a built-in saturation indicator, a tamper-resistant design, and easy-to-read results available in approximately 5 minutes.
The device helps simplify specimen collection, reduces opportunities for specimen adulteration and tampering, and allows results to be photocopied for convenient documentation. As with all rapid immunoassay screening devices, any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS), Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS), or another appropriate confirmatory laboratory method before medical, legal, employment, or insurance decisions are made.
The iScreen™ Oral Fluid Drug Screen Cube is a rapid, non-invasive oral fluid drug screening device designed for employment and insurance testing. Using advanced lateral flow chromatographic immunoassay technology, the device provides fast and convenient qualitative detection of nine commonly abused drugs in human oral fluid, with easy-to-read preliminary results available in approximately 5 minutes.
Oral fluid drug screening simplifies the specimen collection process while helping reduce opportunities for specimen substitution, adulteration, and tampering. The integrated saliva collection swab features an easy-to-read saturation indicator, ensuring that a sufficient oral fluid specimen has been collected before testing begins.
The compact, self-contained Cube combines specimen collection and testing into a single device, making it easy to administer in workplace, insurance, occupational health, and professional testing environments. Results can also be photocopied for documentation and record keeping, making the device suitable for routine screening programs.
The iScreen™ Oral Fluid Drug Screen Cube is available in 5 to 10 drug panel configurations, allowing organizations to customize their oral fluid drug testing programs according to their screening requirements. This 9-panel configuration simultaneously screens for Amphetamine (AMP), Barbiturates (BAR), Cocaine (COC), MDMA, Methamphetamine (MET), Methadone (MTD), Opiates (OPI), Oxycodone (OXY), and Phencyclidine (PCP) from a single oral fluid specimen.
This assay provides preliminary qualitative screening results only. Any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS), Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS), or other appropriate confirmatory laboratory methods before medical, legal, employment, or insurance decisions are made.The iScreen™ Oral Fluid Drug Screen Cube is intended for in vitro diagnostic use only and is designed specifically for employment and insurance testing
This 9 Panel configuration screens for:
Drug
Typical Oral Fluid Detection Window
Amphetamine (AMP)
24–48 Hours
Barbiturates (BAR)
1–2 Days
Cocaine (COC)
24–48 Hours
MDMA
24–48 Hours
Methamphetamine (MET)
24–72 Hours
Methadone (MTD)
24–48 Hours
Opiates (OPI)
24–48 Hours
Oxycodone (OXY)
24–48 Hours
Phencyclidine (PCP)
24–72 Hours
A colored line appears in both the Control (C) region and the Test (T) region for each drug panel. Even a faint Test (T) line should be interpreted as a negative result, indicating that the drug concentration is below the established screening cutoff level.
Only one colored line appears in the Control (C) region while no line appears in the corresponding Test (T) region. This indicates that the drug concentration may be at or above the screening cutoff level. Any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS), Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS), or another appropriate confirmatory laboratory method before medical, legal, employment, or insurance decisions are made.
If no colored line appears in the Control (C) region, the test is invalid regardless of whether a Test line appears. Repeat the test using a new device and a fresh oral fluid specimen
iScreen™ Cube 9 Panel Oral Fluid Drug Screen Cube | Abbott | Amphetamine (AMP)Barbiturates (BAR)Cocaine (COC)MDMA (Ecstasy)Methamphetamine (MET)Methadone (MTD)Opiates (OPI)Oxycodone (OXY)Phencyclidine (PCP) | ABTOFCUBE0901A 25/Box
Sign up for updates from leading retailers
